Saely C, Schernthaner G, Brix J, Klauser-Braun R, Zitt E, Drexel H
Wien Klin Wochenschr. 2023; 135(Suppl 1):147-156.
PMID: 37101036
PMC: 10133364.
DOI: 10.1007/s00508-023-02189-1.
Akalu Y, Yeshaw Y, Tesema G, Tiruneh S, Teshale A, Angaw D
Syst Rev. 2022; 11(1):220.
PMID: 36243876
PMC: 9569048.
DOI: 10.1186/s13643-022-02090-4.
Deres L, Eros K, Horvath O, Bencze N, Cseko C, Farkas S
Front Physiol. 2019; 10:624.
PMID: 31178756
PMC: 6537226.
DOI: 10.3389/fphys.2019.00624.
Schernthaner G, Saely C, Schernthaner G, Watschinger B, Drexel H
Wien Klin Wochenschr. 2019; 131(Suppl 1):124-135.
PMID: 30980142
DOI: 10.1007/s00508-019-1460-2.
Deedwania P
J Am Heart Assoc. 2018; 7(20):e010752.
PMID: 30371267
PMC: 6474965.
DOI: 10.1161/JAHA.118.010752.
A Motivational Interviewing Intervention by Pharmacy Students to Improve Medication Adherence.
Abughosh S, Wang X, Serna O, Esse T, Mann A, Masilamani S
J Manag Care Spec Pharm. 2017; 23(5):549-560.
PMID: 28448784
PMC: 10398180.
DOI: 10.18553/jmcp.2017.23.5.549.
Assessing Cardiovascular Risk and Testing in Type 2 Diabetes.
Saeed A, Ballantyne C
Curr Cardiol Rep. 2017; 19(3):19.
PMID: 28220465
DOI: 10.1007/s11886-017-0831-4.
[Antihypertensive therapy in diabetes mellitus: Guidelines of the Austrian Diabetes Association 2016].
Schernthaner G, Drexel H, Rosenkranz A, Schernthaner G, Watschinger B
Wien Klin Wochenschr. 2016; 128 Suppl 2:S62-7.
PMID: 27052224
DOI: 10.1007/s00508-015-0924-2.
A Pharmacist Telephone Intervention to Identify Adherence Barriers and Improve Adherence Among Nonadherent Patients with Comorbid Hypertension and Diabetes in a Medicare Advantage Plan.
Abughosh S, Wang X, Serna O, Henges C, Masilamani S, Essien E
J Manag Care Spec Pharm. 2016; 22(1):63-73.
PMID: 27015053
PMC: 10397653.
DOI: 10.18553/jmcp.2016.22.1.63.
Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses.
Brunstrom M, Carlberg B
BMJ. 2016; 352:i717.
PMID: 26920333
PMC: 4770818.
DOI: 10.1136/bmj.i717.
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.
Fox C, Golden S, Anderson C, Bray G, Burke L, de Boer I
Diabetes Care. 2015; 38(9):1777-803.
PMID: 26246459
PMC: 4876675.
DOI: 10.2337/dci15-0012.
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.
Fox C, Golden S, Anderson C, Bray G, Burke L, de Boer I
Circulation. 2015; 132(8):691-718.
PMID: 26246173
PMC: 9728095.
DOI: 10.1161/CIR.0000000000000230.
Blood pressure targets for hypertension in people with diabetes mellitus.
Arguedas J, Leiva V, Wright J
Cochrane Database Syst Rev. 2013; (10):CD008277.
PMID: 24170669
PMC: 11365096.
DOI: 10.1002/14651858.CD008277.pub2.
[Antihypertensive therapy in diabetes mellitus - 2012 guidelines of the Austrian Diabetes Association].
Schernthaner G, Drexel H, Rosenkranz A, Schernthaner G, Watschinger B
Wien Klin Wochenschr. 2012; 124 Suppl 2:23-7.
PMID: 23250458
DOI: 10.1007/s00508-012-0270-6.
